Gene theraphy for human lung cancer

S. G. Swisher; J. A. Roth

doi:10.1016/s1055-3207(18)30263-1

Gene theraphy for human lung cancer

S. G. Swisher
, J. A. Roth

Thoracic & Cardiovascular Surgery

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, loco-regional delivery, and the ability to target tumor tissue in a safe manner.

Original language	English (US)
Pages (from-to)	603-616
Number of pages	14
Journal	Surgical oncology clinics of North America
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/s1055-3207(18)30263-1
State	Published - 1998

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1016/s1055-3207(18)30263-1

Cite this

@article{2408a15e188746af8f125f955840e899,

title = "Gene theraphy for human lung cancer",

abstract = "Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, loco-regional delivery, and the ability to target tumor tissue in a safe manner.",

author = "Swisher, \{S. G.\} and Roth, \{J. A.\}",

year = "1998",

doi = "10.1016/s1055-3207(18)30263-1",

language = "English (US)",

volume = "7",

pages = "603--616",

journal = "Surgical oncology clinics of North America",

issn = "1055-3207",

publisher = "W.B. Saunders",

number = "3",

}

TY - JOUR

T1 - Gene theraphy for human lung cancer

AU - Swisher, S. G.

AU - Roth, J. A.

PY - 1998

Y1 - 1998

N2 - Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, loco-regional delivery, and the ability to target tumor tissue in a safe manner.

AB - Gene therapy, in the future, may offer new strategies to treat various malignancies in lung cancer. Several phase I trials have demonstrated the safety of these approaches. The limitation of current gene transfer techniques include transient gene expression, loco-regional delivery, and the ability to target tumor tissue in a safe manner.

UR - https://www.scopus.com/pages/publications/0031596386

UR - https://www.scopus.com/pages/publications/0031596386#tab=citedBy

U2 - 10.1016/s1055-3207(18)30263-1

DO - 10.1016/s1055-3207(18)30263-1

M3 - Review article

C2 - 9624220

AN - SCOPUS:0031596386

SN - 1055-3207

VL - 7

SP - 603

EP - 616

JO - Surgical oncology clinics of North America

JF - Surgical oncology clinics of North America

IS - 3

ER -

Gene theraphy for human lung cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this